(Q35834811)

10 August 2017

1 reference

title

Tumor necrosis factor-alpha in psoriasis and psoriatic arthritis: a clinical, genetic, and histopathologic perspective (English)

1 reference

10 August 2017

1 reference

David Kane

1

1 reference

10 August 2017

Oliver FitzGerald

series ordinal

2

1 reference

10 August 2017

publication date

1 August 2004

1 reference

Current Rheumatology Reports

10 August 2017

published in

1 reference

10 August 2017

volume

6

1 reference

10 August 2017

issue

4

1 reference

10 August 2017

page(s)

292-298

1 reference

A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience

10 August 2017

cites work

1 reference

12 December 2020

Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial

1 reference

12 December 2020

Differential association of polymorphisms in the TNFalpha region with psoriatic arthritis but not psoriasis

1 reference

12 December 2020

Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation

1 reference

12 December 2020

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

1 reference

12 December 2020

Treatment of psoriatic arthritis with antitumour necrosis factor-alpha antibody clears skin lesions of psoriasis resistant to treatment with methotrexate

1 reference

12 December 2020

Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death.

1 reference

12 December 2020

Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-alpha

1 reference

12 December 2020

Genetic epidemiology. Psoriatic arthritis

1 reference

12 December 2020

The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription.

1 reference

12 December 2020

Etanercept for severe psoriasis and psoriatic arthritis: observations on combination therapy

1 reference

12 December 2020

Tumour necrosis factor-alpha polymorphism and the HLA-Cw*0602 allele in psoriatic arthritis

1 reference

12 December 2020

Mechanisms that regulate the production and effects of tumor necrosis factor-alpha

1 reference

12 December 2020

Serum TNF-alpha levels correlate with disease severity and are reduced by effective therapy in plaque-type psoriasis

1 reference

12 December 2020

Natural history of psoriatic arthritis

1 reference

12 December 2020

Role of cytokines in inflammatory synovitis. The coordinate regulation of intercellular adhesion molecule 1 and HLA class I and class II antigens in rheumatoid synovial fibroblasts

1 reference

12 December 2020

Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis

1 reference

12 December 2020

The role of cytokines in the pathogenesis of rheumatoid arthritis

1 reference

12 December 2020

T cell derived cytokines in psoriatic arthritis synovial fluids

1 reference

12 December 2020

Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis

1 reference

12 December 2020

New treatments for psoriasis

1 reference

12 December 2020

Cytokine gene polymorphisms: Association with psoriatic arthritis susceptibility and severity

1 reference

12 December 2020

The expanding universe of T-cell subsets: Th1, Th2 and more.

1 reference

12 December 2020

Immunology of psoriasis and psoriatic arthritis

1 reference

12 December 2020

A TNF-alpha promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis

1 reference

12 December 2020

Development of psoriasis after syngeneic bone marrow transplant from psoriatic donor: further evidence for adoptive autoimmunity

1 reference

12 December 2020

Tumor necrosis factor

1 reference

12 December 2020

A genetic and statistical study of psoriasis

1 reference

12 December 2020

Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial

1 reference

12 December 2020

Psoriatic arthritis: a quantitative overview of therapeutic options. The Psoriatic Arthritis Meta-Analysis Study Group

1 reference

12 December 2020

Familial occurrence of psoriatic arthritis

1 reference

12 December 2020

Psoriatic arthritis (PA): a clinical, immunological and radiological study of 180 patients

1 reference

12 December 2020

Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis

1 reference

12 December 2020

Psoriatic arthritis. Follow-up study

1 reference

12 December 2020

1 reference

12 December 2020

Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study

1 reference

12 December 2020

Characterization of Mononuclear Cell Infiltrates in Psoriatic Lesions

1 reference

12 December 2020

Treatment of recalcitrant psoriatic arthritis with anti-tumor necrosis factor-alpha antibody

1 reference

12 December 2020

Infliximab monotherapy provides rapid and sustained benefit for plaque-type psoriasis

1 reference

12 December 2020

MICA rather than MICB, TNFA, or HLA-DRB1 is associated with susceptibility to psoriatic arthritis.

1 reference

12 December 2020

Expression of interleukin 10 mRNA and protein by synovial fibroblastoid cells

1 reference

12 December 2020

Open-label study of infliximab treatment for psoriatic arthritis: clinical and magnetic resonance imaging measurements of reduction of inflammation

1 reference

12 December 2020

Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis

1 reference

12 December 2020

Etanercept as monotherapy in patients with psoriasis

1 reference

12 December 2020

Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor antagonist.

1 reference

12 December 2020

Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes.

1 reference

12 December 2020

Upregulation of cytokine receptors sTNF-R55, sTNF-R75, and sIL-2R in psoriatic arthritis synovial fluid

1 reference

12 December 2020

Patterns of cytokine production in psoriatic synovium

1 reference

12 December 2020

Pharmacodynamic and pharmacokinetic response to anti-tumor necrosis factor-alpha monoclonal antibody (infliximab) treatment of moderate to severe psoriasis vulgaris

1 reference

12 December 2020

Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines

1 reference

12 December 2020

Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis

1 reference

12 December 2020

Successful treatment of severe recalcitrant psoriasis with combination infliximab and methotrexate

1 reference

12 December 2020

Treatment with anti-tumor necrosis factor alpha (TNF-alpha) monoclonal antibody dramatically decreases the clinical activity of psoriasis lesions

1 reference

12 December 2020

An important role of tumor necrosis factor-alpha in the induction of adhesion molecules in psoriasis

1 reference

12 December 2020

In situ characterization and counting of mononuclear cells in lesions of different clinical forms of psoriasis

1 reference

12 December 2020

Lack of association between promoter polymorphism of the tumor necrosis factor-alpha gene and psoriatic arthritis in Japanese patients

1 reference

12 December 2020

Spreading of psoriatic plaques: alteration of epidermal differentiation precedes capillary leakiness and anomalies in vascular morphology

1 reference

12 December 2020

HLA antigens in psoriatic arthritis

1 reference

12 December 2020

Highly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriatic arthritis synovial fluid

1 reference

12 December 2020

Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1

1 reference

12 December 2020

Potential of tumor necrosis factor inhibitors in psoriasis and psoriatic arthritis

1 reference

12 December 2020

Cytokine pathways and joint inflammation in rheumatoid arthritis

1 reference

12 December 2020

10.1007/S11926-004-0041-0

Identifiers

DOI

1 reference

10 August 2017

1 reference